Newsroom

Sorted by: Latest

-

NuScale Power Implements Everstar’s Gordian AI Platform to Accelerate Commercial Reactor Deployment

CORVALLIS, Ore. & NEW YORK--(BUSINESS WIRE)--NuScale Power deploys Everstar’s nuclear-specific AI platform Gordian to accelerate commercial reactor deployment....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Growth Strength UCITS ETF 17.11.2026 FTGS.LN IE000YZLMXT9   25,002.00 USD    572,953.64   22.916  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - February 17.11.2026 GFEB.LN IE000X8M8M80  600,002.00 USD  23,756,611.63   39.594  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest S&P 500 Dividend Aristocrats Target Income UCITS ETF 17.11.2026 KNG.LN IE000SNMGYT5 1,400,002.00 USD  30,110,739.35   21.508  ...
-

Thomas H. Glocer to Retire From Merck Board of Directors in May 2027; Douglas M. Baker, Jr. Appointed Independent Lead Director

RAHWAY, N.J.--(BUSINESS WIRE)--Thomas H. Glocer to Retire From Merck Board of Directors in May 2027; Douglas M. Baker, Jr. Appointed Independent Lead Director...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Global Aerospace & Defence UCITS ETF 17.11.2026 MISL.LN IE000NVDQXE1 4,375,002.00 USD 136,552,194.46   31.212  ...
-

Pfizer Enters into Exclusive Licensing Agreement with Starna Therapeutics for Autoimmune Diseases

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that it entered into an exclusive licensing agreement with Starna Therapeutics, a biotechnology company developing RNA medicines designed to enable in vivo therapeutics. Under the agreement, Pfizer obtains exclusive rights outside Greater China to develop, manufacture and commercialize three pre-IND in vivo chimeric antigen receptor T-cell (CAR-T) programs that are focused on treating autoimmune diseases. Pfizer also receives ri...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST BLOOMBERG GLOBAL SEMICONDUCTOR SUPPLY CHAIN UCITS ETF 17.11.2026 CHPS.LN IE000KXTLDE2  750,002.00 USD  28,838,491.17   38.451  ...
-

Atmus Filtration Technologies Declares Quarterly Dividend

NASHVILLE, Tenn.--(BUSINESS WIRE)--Atmus declares a quarterly cash dividend of $0.06 per share, payable Dec. 16, 2026, to shareholders of record Dec. 1....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Momentum UCITS ETF 17.11.2026 FTMO.LN IE000CY30YV9 3,125,002.00 USD  88,186,886.76   28.220  ...